MarketInOut Stock Screener Log In | Sign Up

Corbus Pharmaceuticals Holdings Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Corbus Pharmaceuticals Holdings Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization79.69 mln
Float17.36 mln
Earnings Date11/10/2026

Piotroski F-Score

1 / 9
Very weak

1-Year Forecast

34.89
Transformational upside

Relative Strength

20 / 100
Significantly lagging

Debt / Equity

0.04
Debt-free

ROE

-87.97
Deeply negative

ROA

-75.57
Deeply negative

Business Description

Corbus Pharmaceuticals is a clinical-stage company based in Norwood, Massachusetts, focused on developing new treatments for cancer and obesity. Its two lead programs include an antibody-based therapy designed to target and destroy cancer cells, and a weight-loss drug candidate engineered to reduce appetite without affecting the brain. Founded in 2009, the company is working to advance both treatments through clinical development.

Key Fundamentals

EPS-6.11
ROE-87.97
ROIC-1,890
ROA-75.57
EBITDA, mln-102
EV / EBITDA0.26
EV / EBIT0.26

Quote Details

Last 4.22
Change 0 (0%)
Open 4.20
Volume 2,317,176
Turnover 9,778,482
Average Volume 963,705

Financial Ratios

Leverage Ratio1.24
Current Ratio5.71
Price / Book0.76
Price / Tangible Book0.76
Debt / Equity0.04

Financial Strength

Piotroski F-Score 1 / 9
1-Year Target Price34.89
Short Ratio2.68
Short % of Float16.06

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.2% 87 / 100   
1 Month -33.44% 10 / 100   
2 Months -53.52% 7 / 100   
6 Months -59.03% 10 / 100   
1 Year -74.97% 11 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog